Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Finasteride reduces DHT levels and affects gene expression in fish, similar to its effects in humans.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.

The research found that certain genes are linked to male pattern baldness, but these same genes do not affect female pattern hair loss.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Red Ginseng Extract may help human hair grow by activating growth pathways and blocking negative effects of certain hormones.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Increased PPARGC1α relates to hair thinning in common baldness.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Certain factors can trigger hormonal imbalances and cyst formation, leading to Polycystic Ovarian Syndrome (PCOS).

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

Reducing SFRP1 can promote hair growth and may help treat hair loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Decorin, a protein, may help start hair growth and could be used to treat hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The link between anabolic agents and colorectal cancer risk is unclear.